1. Friedman CR, Neimann J, Wegener HC et al. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nachamkin I, Blaser MJ, eds. Campylobacter. Washington, DC: ASM Press, 2000; 121–38.
2. Nachamkin I, Allos BM, Ho TW. Campylobacter jejuni infection and the association with Guillain–Barre syndrome. In: Nachamkin I, Blaser MJ, eds. Campylobacter. Washington, DC: ASM Press, 2000; 155–75.
3. Newell DG, Wagenaar JA. Poultry infections and their control at the farm level. In: Nachamkin I, Blaser MJ, eds. Campylobacter. Washington, DC: ASM Press, 2000; 497–509.
4. Engberg J, Aarestrup FM, Taylor DE et al. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis2001; 7: 24–34.
5. Lin J, Akiba M, Zhang QJ. Multidrug efflux systems in Campylobacter. In: Ketley JM, Konkel ME, eds. Campylobacter: Molecular and Cellular Biology. Norfolk: Horizon BioScience, 2005; 205–18.